Q2 2021 13F Holders as of 6/30/2021
-
Type / Class
-
Equity / American Depositary Shares
-
Shares outstanding
-
7.74M
-
Number of holders
-
12
-
Total shares
-
536K
-
Shares change
-
+44.3K
-
Total reported value, excl. options
-
$4.35M
-
Value change
-
+$398K
-
Put/Call ratio
-
0.65
-
Number of buys
-
6
-
Number of sells
-
-5
-
Price
-
$9.87
Significant Holders of Kazia Therapeutics Limited - American Depositary Shares (KZIA) as of Q2 2021
14 filings reported holding KZIA - Kazia Therapeutics Limited - American Depositary Shares as of Q2 2021.
Kazia Therapeutics Limited - American Depositary Shares (KZIA) has 12 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 536K shares
of 7.74M outstanding shares and own 6.93% of the company stock.
Largest 10 shareholders include MORGAN STANLEY (234K shares), Transform Wealth, LLC (106K shares), RENAISSANCE TECHNOLOGIES LLC (65.8K shares), SG Americas Securities, LLC (44.4K shares), TRUIST FINANCIAL CORP (29K shares), ACT Capital Management, LLC (25K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (14.3K shares), CITADEL ADVISORS LLC (12.8K shares), SIMPLEX TRADING, LLC (4.58K shares), and Steward Partners Investment Advisory, LLC (100 shares).
This table shows the top 12 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.